P+P advises SHS on first closing of its fifth fund with over EUR 90 m
SHS Gesellschaft für Beteiligungsmanagement mbH, Tübingen, (SHS) has received investments of over EUR 90 m with the first closing of SHS V Medtech Investments GmbH & Co. KG. P+P Pöllath + Partners advised the management of SHS within the scope of the closing.
Thanks to great demand by institutional investors and family offices, SHS achieved almost two thirds of the target amount of EUR 150 m more quickly than expected. The new fifth fund targets the life sciences and medical engineering sector and thereby the globally growing health market with innovative, strong companies, primarily in Germany and Switzerland. There are 12 to 15 planned commitments with a maximum investment amount of EUR 30 m per investment.
Tübingen-based SHS invests in medical engineering and life science companies with a focus on expansion financing, change of partners and succession situations.
P+P Pöllath + Partners advised SHS on all contractual, tax and regulatory aspects of the fund structuring and launch, as well as the marketing with the following Berlin-based fund team: